New drug interactions and warnings are being reported for Posicor (mibefradil)
February 1998
Two important new drug interactions and warnings are being reported for Posicor (mibefradil)...the new calcium channel blocker for hypertension and angina.
These interactions probably aren't in your computer yet.
Posicor alone can slow the heart rate...and even more so when it's combined with other drugs that also slow heart rate.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote